Cargando…

Efficacy and safety of Maekmoondong-tang for chronic dry cough: a study protocol for a randomized controlled trial

BACKGROUND: Chronic cough, defined it lasts more than 8 weeks. The symptom is common, but highly troublesome, and it reduces quality of life. Despite much effort to develop a protocol for diagnosis and treatment of chronic cough, it remains problematic to determine its cause. As a result, treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kwan-Il, Shin, Seungwon, Kim, Kyuseok, Lee, Junhee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736174/
https://www.ncbi.nlm.nih.gov/pubmed/26829923
http://dx.doi.org/10.1186/s12906-016-1028-x
_version_ 1782413225299542016
author Kim, Kwan-Il
Shin, Seungwon
Kim, Kyuseok
Lee, Junhee
author_facet Kim, Kwan-Il
Shin, Seungwon
Kim, Kyuseok
Lee, Junhee
author_sort Kim, Kwan-Il
collection PubMed
description BACKGROUND: Chronic cough, defined it lasts more than 8 weeks. The symptom is common, but highly troublesome, and it reduces quality of life. Despite much effort to develop a protocol for diagnosis and treatment of chronic cough, it remains problematic to determine its cause. As a result, treatment is often unsuccessful. Thus, there is much interest regarding the use of symptomatic drugs to control chronic cough. Maekmoondong-tang is widely used in East Asian countries to treat chronic dry cough. Several experimental studies have reported that the herbal medicine has immunomodulatory and antitussive effects. Clinical studies involving Maekmoondong-tang have also been carried out; however, these studies have involved treating various diseases as a whole rather than chronic cough itself. Thus, we aim to evaluate the efficacy and safety of Maekmoondong-tang in chronic dry cough patients with a randomized controlled trial. METHODS/DESIGN: This study is designed as an exploratory, single-center, placebo-controlled, double-blind, randomized, parallel group clinical trial. Patients with dry cough that has lasted more than 8 weeks will be recruited, after a 1-week run-in period, and randomly allocated to either the Maekmoondong-tang treatment group or the placebo group. The patients will receive Maekmoondong-tang or placebo granules 3 times daily for 4 weeks, with a 2-week follow-up. The primary outcome is a 10-point cough diary that will be recorded on a daily basis. The secondary outcomes comprise a cough visual analog scale, the Leicester Cough Questionnaire (Korean version), the Pattern Identification for Chronic Cough Questionnaire, biomarkers, safety testing, etc. Adverse events will also be reported. DISCUSSION: This trial will assess the efficacy and safety of Maekmoondong-tang in chronic dry cough. TRIAL REGISTRATION: Korean Clinical Trial Registry (http://cris.nih.go.kr; registration number: KCT0001646). Date of registration: October 5 2015
format Online
Article
Text
id pubmed-4736174
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47361742016-02-03 Efficacy and safety of Maekmoondong-tang for chronic dry cough: a study protocol for a randomized controlled trial Kim, Kwan-Il Shin, Seungwon Kim, Kyuseok Lee, Junhee BMC Complement Altern Med Study Protocol BACKGROUND: Chronic cough, defined it lasts more than 8 weeks. The symptom is common, but highly troublesome, and it reduces quality of life. Despite much effort to develop a protocol for diagnosis and treatment of chronic cough, it remains problematic to determine its cause. As a result, treatment is often unsuccessful. Thus, there is much interest regarding the use of symptomatic drugs to control chronic cough. Maekmoondong-tang is widely used in East Asian countries to treat chronic dry cough. Several experimental studies have reported that the herbal medicine has immunomodulatory and antitussive effects. Clinical studies involving Maekmoondong-tang have also been carried out; however, these studies have involved treating various diseases as a whole rather than chronic cough itself. Thus, we aim to evaluate the efficacy and safety of Maekmoondong-tang in chronic dry cough patients with a randomized controlled trial. METHODS/DESIGN: This study is designed as an exploratory, single-center, placebo-controlled, double-blind, randomized, parallel group clinical trial. Patients with dry cough that has lasted more than 8 weeks will be recruited, after a 1-week run-in period, and randomly allocated to either the Maekmoondong-tang treatment group or the placebo group. The patients will receive Maekmoondong-tang or placebo granules 3 times daily for 4 weeks, with a 2-week follow-up. The primary outcome is a 10-point cough diary that will be recorded on a daily basis. The secondary outcomes comprise a cough visual analog scale, the Leicester Cough Questionnaire (Korean version), the Pattern Identification for Chronic Cough Questionnaire, biomarkers, safety testing, etc. Adverse events will also be reported. DISCUSSION: This trial will assess the efficacy and safety of Maekmoondong-tang in chronic dry cough. TRIAL REGISTRATION: Korean Clinical Trial Registry (http://cris.nih.go.kr; registration number: KCT0001646). Date of registration: October 5 2015 BioMed Central 2016-02-02 /pmc/articles/PMC4736174/ /pubmed/26829923 http://dx.doi.org/10.1186/s12906-016-1028-x Text en © Kim et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Kim, Kwan-Il
Shin, Seungwon
Kim, Kyuseok
Lee, Junhee
Efficacy and safety of Maekmoondong-tang for chronic dry cough: a study protocol for a randomized controlled trial
title Efficacy and safety of Maekmoondong-tang for chronic dry cough: a study protocol for a randomized controlled trial
title_full Efficacy and safety of Maekmoondong-tang for chronic dry cough: a study protocol for a randomized controlled trial
title_fullStr Efficacy and safety of Maekmoondong-tang for chronic dry cough: a study protocol for a randomized controlled trial
title_full_unstemmed Efficacy and safety of Maekmoondong-tang for chronic dry cough: a study protocol for a randomized controlled trial
title_short Efficacy and safety of Maekmoondong-tang for chronic dry cough: a study protocol for a randomized controlled trial
title_sort efficacy and safety of maekmoondong-tang for chronic dry cough: a study protocol for a randomized controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736174/
https://www.ncbi.nlm.nih.gov/pubmed/26829923
http://dx.doi.org/10.1186/s12906-016-1028-x
work_keys_str_mv AT kimkwanil efficacyandsafetyofmaekmoondongtangforchronicdrycoughastudyprotocolforarandomizedcontrolledtrial
AT shinseungwon efficacyandsafetyofmaekmoondongtangforchronicdrycoughastudyprotocolforarandomizedcontrolledtrial
AT kimkyuseok efficacyandsafetyofmaekmoondongtangforchronicdrycoughastudyprotocolforarandomizedcontrolledtrial
AT leejunhee efficacyandsafetyofmaekmoondongtangforchronicdrycoughastudyprotocolforarandomizedcontrolledtrial